Back
Turn Therapeutics Slides 7.8% as 2026 Outlook Disappoints Investors
Back
Stock News
Themes
Turn Therapeutics Slides 7.8% as 2026 Outlook Disappoints Investors
Turn Therapeutics Slides 7.8% as 2026 Outlook Disappoints Investors
Edgen Stock
·
Jan 12 2026, 18:26
Share to
Share to
Copy link
TTRX
-3.63%
source:
[1] Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44th Annual J.P. Morgan Healthcare Conference
Recommend
Enterprise Products Partners Nears Financial Inflection Point, Poised for Enhanced Shareholder Returns
Nov 28 2025, 10:17
US-China AI Rivalry Enters New Phase Focused on Compute Power and Cybersecurity
Nov 28 2025, 10:17
Enterprise Products Partners Nears Financial Inflection Point, Poised for Enhanced Shareholder Returns
Nov 28 2025, 10:17